A Multi-targeted Approach to Suppress Tumor-Promoting Inflammation

Cancers harbor significant genetic heterogeneity and patterns of relapse following many therapies are due to evolved resistance to treatment. While efforts have been made to combine targeted therapies, significant levels of toxicity have stymied efforts to effectively treat cancer with multi-drug co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Semin Cancer Biol
Autors principals: Samadi, Abbas K., Georgakilas, Alexandros G., Amedei, Amedeo, Amin, Amr, Bishayee, Anupam, Lokeshwar, Bal L., Grue, Brendan, Panis, Carolina, Boosani, Chandra S., Poudyal, Deepak, Stafforini, Diana M., Bhakta, Dipita, Niccolai, Elena, Guha, Gunjan, Rupasinghe, H.P. Vasantha, Fujii, Hiromasa, Honoki, Kanya, Mehta, Kapil, Aquilano, Katia, Lowe, Leroy, Hofseth, Lorne J., Ricciardiello, Luigi, Ciriolo, Maria Rosa, Singh, Neetu, Whelan, Richard L., Chaturvedi, Rupesh, Ashraf, S. Salman, Kumara, HMC Shantha, Nowsheen, Somaira, Mohammed, Sulma I., Helferich, William G., Yang, Xujuan
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635070/
https://ncbi.nlm.nih.gov/pubmed/25951989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2015.03.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars